The significant enrichment in MYC target genes and the high expression of cancer stemness genes that we observed in CTCs with a platelet gene signature suggest the pro-oncogenic nature of this interaction, in agreement with the findings of studies in other tumor types [42]. The gene discussed is MYC; the disease is cancer.